De novo loss-of-function variants of ASH1L are associated with an emergent neurodevelopmental disorder

Eur J Med Genet. 2019 Jan;62(1):55-60. doi: 10.1016/j.ejmg.2018.05.003. Epub 2018 May 22.

Abstract

De novo variants of ASH1L, which encodes a histone methyltransferase, have been reported in a few patients with intellectual disability and autistic features. Here, we identified a novel de novo frame-shift variant, c.2422_2423delAAinsT which predicts p.(Lys808TyrfsTer40), in ASH1L in a patient with multiple congenital anomalies (MCA), fine motor developmental delay, learning difficulties, attention deficit hyperactivity disorder, sleep apnea, and scoliosis. This frame-shift variant is expected to result in loss-of-function. Our report provides further evidence to support loss-of-function alterations of ASH1L as causative for an emergent neurodevelopmental syndrome characterized by MCA, intellectual disability, and behavioral problems, and further delineates this genetic disorder.

Keywords: Autism spectrum disorder; Exome sequencing; Intellectual disability; Multiple congenital anomalies.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Multiple / genetics*
  • Abnormalities, Multiple / pathology
  • Child
  • DNA-Binding Proteins / genetics*
  • Developmental Disabilities / genetics*
  • Developmental Disabilities / pathology
  • Histone-Lysine N-Methyltransferase
  • Humans
  • Loss of Function Mutation*
  • Male
  • Phenotype*
  • Syndrome
  • Transcription Factors / genetics*

Substances

  • DNA-Binding Proteins
  • Transcription Factors
  • ASH1L protein, human
  • Histone-Lysine N-Methyltransferase